Skip to Main Content

Author Details

Iacopo Petrini
University of Pisa
2006
78
26
PMIDPaper TitleJournal TitlePublished Year
36736684Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.Clin Chim Acta2023
37671056Somatic mutations of thymic epithelial tumors with myasthenia gravis.Front Oncol2023
38023142Editorial: Primary and acquired resistance in lung cancer.Front Oncol2023
37094664STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.J Thorac Oncol2023
37473500Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC.Lung Cancer2023
37372430Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data.Genes (Basel)2023
37239097Mesenchymal Stem Cell in Pancreatic Islet Transplantation.Biomedicines2023
36736684Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.Clin Chim Acta2023
37671056Somatic mutations of thymic epithelial tumors with myasthenia gravis.Front Oncol2023
38023142Editorial: Primary and acquired resistance in lung cancer.Front Oncol2023
37239097Mesenchymal Stem Cell in Pancreatic Islet Transplantation.Biomedicines2023
37372430Papillary Thyroid Carcinoma: A thorough Bioinformatic Analysis of Gene Expression and Clinical Data.Genes (Basel)2023
37473500Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC.Lung Cancer2023
37094664STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.J Thorac Oncol2023
35151155Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.Cancer Treat Rev2022
36246734Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.Onco Targets Ther2022
35841107Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing.Genome Biol2022
35739016Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival.Clin Lung Cancer2022
35681572ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach.Cancers (Basel)2022
36402755Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.Cell Death Dis2022
36517829Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.J Exp Clin Cancer Res2022
35151155Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours.Cancer Treat Rev2022
35739016Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival.Clin Lung Cancer2022
35841107Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing.Genome Biol2022
35681572ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach.Cancers (Basel)2022
36517829Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.J Exp Clin Cancer Res2022
36402755Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.Cell Death Dis2022
36246734Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations.Onco Targets Ther2022
33358889Thymectomy in Myasthenic Patients With Thymoma: Killing Two Birds With One Stone.Ann Thorac Surg2021
34178662Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.Front Oncol2021
34116501Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM).ESMO Open2021
33940185Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.Pharmacol Res2021
33613510Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results.Front Immunol2021
34350272Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results.Ann Transl Med2021
33315149A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.Cancer Immunol Immunother2021
33358889Thymectomy in Myasthenic Patients With Thymoma: Killing Two Birds With One Stone.Ann Thorac Surg2021
34992817Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients.J Thorac Dis2021
33613510Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results.Front Immunol2021
34992817Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patients.J Thorac Dis2021
33940185Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives.Pharmacol Res2021
34350272Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results.Ann Transl Med2021
34178662Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation.Front Oncol2021
34116501Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM).ESMO Open2021
33315149A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.Cancer Immunol Immunother2021
32170942Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?Interact Cardiovasc Thorac Surg2020
31735523Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.Clin Lung Cancer2020
32170942Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?Interact Cardiovasc Thorac Surg2020
33489892Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer.Front Oncol2020
32820012erbB in NSCLC as a molecular target: current evidences and future directions.ESMO Open2020
33489892Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer.Front Oncol2020
  • 1 - 50 of 156

Recommended Authors

Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Yang Shao
Nanjing Geneseeq Technology Inc.
Career Start Year 2012
Number of shared co-authors 0
Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
Career Start Year 2009
Number of shared co-authors 0
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 2
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2007
Number of shared co-authors 1
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 0
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 1
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 2
Timo Gaiser
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 5
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 1
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Anthony J Iafrate
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 2
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 2
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Enrique de Alava
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Career Start Year 1992
Number of shared co-authors 3
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 2
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 2
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 7
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 1
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 3

Collaborators

Marzia Del Re
University of Pisa
Co-authored papers 25
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers 16
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 9
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Trung Pham
Stanford University
Co-authored papers 4
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Donna Voeller
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Jonathan K Killian
From Foundation Medicine
Co-authored papers 3
James Gao
National Eye Institute, National Institutes of Health
Co-authored papers 2
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Annalisa Trama
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 2
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Aykut Uren
Georgetown University Medical Center
Co-authored papers 1
Garrett T Graham
Co-authored papers 1
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Habtom W Ressom
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 1
Amrita K Cheema
Co-authored papers 1
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 1
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Yuval Dor
Hadassah-Hebrew University Medical Center
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Liang Cao
National Cancer Institute, National Institutes of Health
Co-authored papers 1
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers 1
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Co-authored papers 1
Release 1.2